ZEU-22191-13011
4 vaccinations
5 coded responses
36 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 088 / NJ
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-23
Registered in v-safe
-
2021-03-23
Dose 1 — Pfizer-BioNTech
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
-
2021-04-13
Dose 2 — Pfizer-BioNTech
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Fatigue or tirednessAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-18
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Fatigue or tirednessAdult check-in
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-05-25
- 2021-07-13
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Discharge, Fatigue, Nasal discomfort, Pre-existing disease, Respiratory symptom — Feeling: GoodFree text: In August of this year I had one day of mild upper respiratory symptoms; excessive drainage, burning sensation in nasal passages and mild fatigue but no fever. Symptoms cleared in less than 24 hours and weren't too different from fall allergies.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-19
Dose 3 — Pfizer-BioNTech
- 2022-04-13
- 2022-04-19
-
2022-10-14
Dose 4 — Pfizer-BioNTech
-
2022-10-19
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-10-19
Survey response — 12 months, dose 3MedDRA: Fatigue — Feeling: GoodFree text: After my latest booster, on 10/14/22, I experienced fatigue about 24 hours after the vaccination that lasted about 24 hours.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-10-21
- 2022-10-28
-
2022-11-04
Survey response — day 21, dose 4MedDRA: Fatigue, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, fatigue and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-11-04
Report sent to call center — day 21, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-11-07
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-11
-
2022-11-18
Survey response — day 35, dose 4MedDRA: Respiratory symptom — Feeling: FairFree text: On 11/17 I had the best nest of minor upper respiratory symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
- 2023-01-13
-
2023-04-14
Survey response — 6 months, dose 4MedDRA: Hypersensitivity — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-04-14
Report sent to call center — 6 months, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2023-04-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-23 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
| 4 | 2022-10-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-04 | Successful 2022-11-07 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2023-04-14 | Successful 2023-04-17 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — 6 months, dose 2
Symptoms: In August of this year I had one day of mild upper respiratory symptoms; excessive drainage, burning sensation in nasal passages and mild fatigue but no fever. Symptoms cleared in less than 24 hours and weren't too different from fall allergies.
Release 12 — 12 months, dose 3
Symptoms: After my latest booster, on 10/14/22, I experienced fatigue about 24 hours after the vaccination that lasted about 24 hours.
Release 12 — day 21, dose 4
Symptoms: Fever, fatigue and runny nose
Release 12 — day 35, dose 4
Symptoms: On 11/17 I had the best nest of minor upper respiratory symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Nasal discomfort | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release